Hannah Crocker

Dr Hannah Crocker is the Advanced Therapy Medicinal Products (ATMP) Outcomes Programme Manager at the NHS Wales Joint Commissioning Committee (NWJCC). Hannah's expertise in the field of advanced therapies developed through her PhD and Postdoctoral research at the University of Bristol, which spanned molecular biology, baculovirus technologies and renal medicine, intending to generate novel gene therapy products for kidney diseases. 

Her role at the NWJCC is now focusing on evaluating the effectiveness and value delivered by ATMPs through the collation and analysis of real-world evidence. This work includes supporting the implementation of patient-reported outcomes collection and utilisation during the delivery of ATMPs, to better facilitate person-centred health care.

• Session: Trends House | ATMP Horizons, Opening Remarks, Thursday 25 September, 16.00-17.00 BST (UTC+1)